Digital Diagnostics
Coralville
About Digital Diagnostics
Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. Founded by Michael Abramoff, MD, PhD, a fellowship-trained retina specialist, neuroscientist, and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists. Digital Diagnostics is paving the way for autonomous AI diagnosis to become the new standard of care, helping to democratize healthcare and close care gaps to improve patient outcomes. By working closely with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders, Digital Diagnostics is working with the healthcare system to enable the continued adoption of autonomous AI.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $173.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: digitaldiagnostics.com
- Phone: 319-248-5620
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/digital-diagnostics-79340 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.